According to Allergan's latest financial reports the company's current earnings (TTM) are -$3.37 B. In 2019 the company made an earning of -$4.34 B an increase over its 2018 earnings that were of -$5.95 B.
Year | Earnings | Change |
---|---|---|
2020 (TTM) | -$3.37 B | -22.39% |
2019 | -$4.34 B | -27.08% |
2018 | -$5.95 B | -36% |
2017 | -$9.3 B | 511.84% |
2016 | -$1.52 B | -41.58% |
2015 | -$2.6 B | 99.91% |
2014 | -$1.31 B | 226.22% |
2013 | -$0.4 B | -210.17% |
2012 | $0.36 B | -32.73% |
2011 | $0.53 B | 60.68% |
2010 | $0.33 B | -15.65% |
2009 | $0.39 B | 2.67% |
2008 | $0.38 B | 51.18% |
2007 | $0.25 B | 237.71% |
2006 | $75.7 M | -65.35% |
2005 | $0.21 B | -17.83% |
2004 | $0.26 B | -21.53% |
2003 | $0.33 B | 25.82% |
2002 | $0.26 B | 165.86% |
2001 | $0.10 B |